secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001609550-25-000030
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q2 net loss $3.6M, cuts FY 2025 revenue guidance to $900-910M
-----------------------------------------------------------------------------

- Q2 revenue $217.1M (+11% YoY), net loss $3.6M vs prior year net income $9.8M.
- Adjusted diluted EPS $0.45; GAAP diluted loss per share $0.12.
- FY 2025 revenue guidance cut to $900-910M (prior $940-955M); EPS cut to $0.40-0.50 from $2.20-2.30.
- Full U.S. launch of Inspire V neurostimulation system initiated.
- EVP Randall Ban to retire on January 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955025000030/0001609550-25-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955025000030/insp-20250804.htm
  HTML page:      https://secwatch.observer/filing/0001609550-25-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer